MEDICATIONS EXCLUDED FROM MAIL-ORDER COVERAGE October 1, 2012

Size: px
Start display at page:

Download "MEDICATIONS EXCLUDED FROM MAIL-ORDER COVERAGE October 1, 2012"

Transcription

1 MEDICATIONS EXCLUDED FROM MAIL-ORDER COVERAGE October 1, 2012 Network Health does not cover the medications listed below for Network Health Forward (Commonwealth Care) Plan Type II and III members or Network Health Extend (Medical Security Plan) Plan Type II and III members through our mail-order vendor, Wellpartner. We list all products alphabetically by their brand name. The brand names are for reference only, and do not mean they are covered. Generic drugs have the same active ingredient and work the same as brand-name drugs. We only cover brand-name medications when a generic medication is not available. Your provider may prescribe the covered medications from the list below for you to fill only at a retail pharmacy or through our specialty pharmacy, Caremark. Some of the medications listed below may have coverage limitations. Excluded mail-order medications (only covered at retail pharmacies) Brand name Abstral Fentanyl SL tablets Accutane Actiq Fentanyl lozenge Adcetris Brentuximab vedotin Adderall, Adderall XR Dextroamphetamine/Amphetamine salts Aloxi Palonosetron Ambien, Ambien CR Zolpidem Amerge Naratriptan Amnesteem Anadrol-50 Oxymetholone Androderm Testosterone transdermal system Androgel Testosterone gel Antabuse Disulfiram Anzemet Dolasetron Apokyn Apomorphine Arixtra Fondaparinux Avinza Morphine sulphate SR 24 hour Axert Almotriptan Axiron Testosterone topical solution AzaSite Azithromycin Azelex Azelaic acid Butrans Buprenorphine patch Cafcit Caffeine citrate Campral Acamprosate Caverject

2 Chantix Cialis Claravis Clozaril Coartem Codeine Phosphate Codeine Sulfate Colyte Commit Concerta Cyclogyl D.H.E. 45 Darvocet-N Darvon Compound Darvon-N Daytrana Delatestryl Demerol Depo-Testosterone Dexedrine Dexferrum DHC Plus Diastat, Diastat AcuDial Dificid Dilaudid Duragesic Edex Edluar Elidel Elimite Embeda Emend Empirin #2, #3, #4 Exalgo Eurax lotion Fentora Feraheme Ferrlecit Finacea Fioricet/Codeine Fiorinal/Codeine First-Testosterone Flector Patch Varenicline Tadalafil Clozapine Artemether/lumefantrine Codeine phosphate Codeine sulfate Nicotine, Polacrilex Methylphenidate ER Cyclopentolate Dihydroergotamine Propoxyphene napsylate/apap Propoxyphene/ASA/Caffeine Propoxyphene napsylate Methylphenidate Testosterone enanthate (in oil) Meperidine Testosterone cypionate Dextroamphetamine Iron Dextran Dihydrocodeine/APAP/Caffeine Diazepam Fidaxomicin Hydromorphone Fentanyl Ambiel SL Pimecrolimus Permethrin Morphine/Naltrexone Aprepitant Codeine/Aspirin Hydromorphone ER Crotamiton Fentanyl buccal tablets Ferumoxytol Ferric Gluconate Azelaic acid Butalbital/APAP/Caffeine/Codeine Butalbital/Aspirin/Caffeine/Codeine Testosterone 2% ointment, 2% cream cmp kit Diclofenac patch

3 Flolan Epoprostenol sodium Flumadine Rimantadine Focalin, Focalin XR Dexmethylphenidate Fortesta Testosterone gel Fragmin Dalteparin Frova Frovatriptan Golytely HalfLytely Helidac Tetracycline/Bismuth/Metronidazole Hycodan Hydrocodone bitartrate Imitrex, Imitrex Inj., Imitrex Nasal Sumatriptan Infed Iron Dextran Innohep Tinzaparin Iprivasc Desirudin Isopto Homatropine 5% Homatropaire 5% Kadian Morphine sulphate SR - 12 hour Koromex Coil Diaphragm Kwell Lindane Kytril Granisetron Lamisil Terbinafine Levitra Vardenafil Lovenox Enoxaparin Lunesta Eszopiclone Marinol Dronabinol Maxalt, Maxalt MLT Rizatriptan Metadate CD Methylphenidate ER Methadone Methadone Methitest Methyltestosterone Migranal, Migranal Nasal Dihydroergotamine Moviprep MS Contin Morphine SR MSIR Morphine Muse Natroba Spinosad Nicotrol, Nicotrol NS Nicotine Nulecit Ferric Gluconate Nulytely Nuvigil Armodafinil Onsolis Fentanyl buccal film Opana, Opana ER Oxymorphone IR, Oxymorphone ER Opium Tincture Opium Tincture Ortho All-Flex Diaphragm OsmoPrep Bowel evacuant

4 Ovide Malathion Oxandrin Oxandrolone Oxycontin Oxycodone ER Oxyfast Oxycodone OxyIR Oxycodone Percocet Oxycodone/APAP Percodan Oxycodone/Aspirin Plan B, Plan B One-Step Levonorgestrel Ponstel Mefenamic acid Pradaxa Dabigatran Prevpac Lansoprazole/Amoxicillin/Clarithromycin Protopic Tacrolimus Provigil Modafinil Prudoxin Doxepin cream Pylera Bismuth subcitrate potassium/metronidazole/tetracycline Reclast Zoledronic acid Relenza Zanamivir Relistor Methylnaltrexone Relpax Eletriptan Reprexain Hydrocodone/Ibuprofen Revia Naltrexone Ritalin, Ritalin SR, Ritalin LA Methylphenidate Rozerem Ramelteon Salicylic Acid 26% Salicylic acid 26% Samsca Tolvaptan Sancuso Granisetron Santyl Ointment Collagenase ointment Solaraze Gel Diclofenac gel Soma Carisoprodol Soma Compound Carisoprodol/Aspirin Sonata Zaleplon Sotret Sprix Ketorolac nasal spray Stadol Butorphanol tartrate Striant Testosterone buccal system Suboxone Buprenorphine/Naloxone Subutex Buprenorphine Suprep Tamiflu Oseltamivir Testopel Testosterone pellets Toradol tablets, vials, cartridges Ketorolac tromethamine Transderm-Scop Scopolamine Trypsin-balsam peru-castor oil Trypsin-balsam peru-castor oil

5 Tussionex Hydrocodone/Chlorpheniramine Tylenol #2, #3, #4 Acetaminophen/Codeine Tylox Oxycodone/APAP Ultracet Tramadol/APAP Ultram, Ultram ER Tramadol, Tramadol ER Urea 40% Cream and Lotion Urea 40% cream and lotion Urea 50% Cream and Ointment Urea 50% cream and ointment Valcyte Valganciclovir Venofer Iron Sucrose Viagra Sildenafil Vicodin, Vicodin ES Acetaminophen/Hydrocodone Vicoprofen Hydrocodone/Ibuprofen Virazole Ribavirin Vyvanse Lisdexamfetamine Xifaxan Rifaximin Xyrem Sodium oxybate Zofran, Zofran ODT Ondansetron Zometa Zoledronic acid Zomig, Zomig ZMT, Zomig Nasal Zolmitriptan Zovirax Cream Acyclovir Zyban Bupropion Zyvox Linezolid Excluded mail-order specialty medications (only covered tthrough Caremark) Brand name See a complete list of medications Caremark provides. Other mail-order exclusions* Peak flow meters Spacers for asthma inhalers All injectable oncology medications All Schedule II and Schedule III controlled substance medications f you are unsure of its status, please call us at to verify that a specific drug is covered under the mail-order benefit. I

State of Louisiana. Department of Health and Hospitals Bureau of Health Services Financing

State of Louisiana. Department of Health and Hospitals Bureau of Health Services Financing Bobby Jindal GOVERNOR Bruce D. Greenstein SECRETARY State of Louisiana Department of Health and Hospitals Bureau of Health Services Financing Re: Quantity Limits, Maximum Dosages and ICD-9-CM Diagnosis

More information

May 31, 2013. Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106

May 31, 2013. Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106 P.O. Box 30449 Salt Lake City, UT 84130-0449 May 31, 2013 Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106 Re: Pharmacy Benefit Coverage Changes Effective

More information

Frequently Asked Questions: HB 341 Mandatory OARRS Registration and Requests

Frequently Asked Questions: HB 341 Mandatory OARRS Registration and Requests Frequently Asked Questions: HB 341 Mandatory OARRS Registration and Requests Q1) What is OARRS? Updated 12-18-2014 OARRS stands for the Ohio Automated Rx Reporting System. Established in 2006, OARRS is

More information

MUSC Opioid Analgesic Comparison Chart

MUSC Opioid Analgesic Comparison Chart MUSC Opioid Analgesic Comparison Chart Approved by the Pharmacy and Therapeutics Committee (February 2006, November 2009, March 2010, December 2011) Prepared by the MUSC Department of Pharmacy Services

More information

Outpatient Detoxification

Outpatient Detoxification Opioid dependence is a challenging and complicated condition, but it can be treated. If you re working to overcome opioid dependence, you know the experience can sometimes be overwhelming. That s why the

More information

What Is a Prescriber s Role in Preventing the Diversion of Prescription Drugs?

What Is a Prescriber s Role in Preventing the Diversion of Prescription Drugs? What Is a Prescriber s Role in Preventing the Diversion of Prescription Drugs? 2 CONTENT SUMMARY Drug diversion is the illegal distribution or abuse of prescription drugs or their use for unintended purposes.

More information

Technician Tutorial: Scheduled Drugs

Technician Tutorial: Scheduled Drugs (Page 1 of 8) Technician Tutorial: Scheduled Drugs In the U.S., the federal Controlled Substances Act (CSA) regulates controlled substances. The U.S. Drug Enforcement Administration (DEA), which is a part

More information

Standard Dispensing Limits (DL)

Standard Dispensing Limits (DL) Standard s (DL) Drug dispensing limits help encourage medication use as intended by the FDA. Coverage limits are placed on medications in certain drug categories. Limits may include: Quantity of covered

More information

QUANTITY LIMITS TABLE

QUANTITY LIMITS TABLE S TABLE / TABLA DE ABILIFY ARIPIPRAZOLE ORAL SOLUTION 900 ML IN 30 DAYS ABILIFY DISCMELT 10 MG ARIPIPRAZOLE TAB RAPDIS 30 TABS IN 30 DAYS ABILIFY DISCMELT 15 MG ARIPIPRAZOLE TAB RAPDIS 60 TABS IN 30 DAYS

More information

Safe Disposal of Medications and Sharps in the Home Setting. American Nurses Association & U.S. Food and Drug Administration

Safe Disposal of Medications and Sharps in the Home Setting. American Nurses Association & U.S. Food and Drug Administration Safe Disposal of Medications and Sharps in the Home Setting American Nurses Association & U.S. Food and Drug Administration Conflicts of Interest Conflicts of Interest occur when an individual has opportunity

More information

CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS

CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS CINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD Kelly Raker 310 Ezzard Charles Dr. Cincinnati, OH 45214 513-564-2233

More information

Opioids to Minors and Drug Donation Programs Objectives By completing the lesson, the pharmacist will be able to:

Opioids to Minors and Drug Donation Programs Objectives By completing the lesson, the pharmacist will be able to: 1 1 1 1 1 1 0 1 0 1 Opioids to Minors and Drug Donation Programs Objectives By completing the lesson, the pharmacist will be able to: Discuss Ohio s new laws concerning use of opioids in minors Describe

More information

Equianalgesic Dosing of Opioids for Pain Management

Equianalgesic Dosing of Opioids for Pain Management PL Detail-Document #280801 This PL Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER August 2012 Equianalgesic Dosing of Opioids for Pain Management

More information

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,

More information

NO-COST PREVENTIVE CARE DRUGS

NO-COST PREVENTIVE CARE DRUGS NO-COST PREVENTIVE CARE DRUGS INFORMATION FOR NON-GRANDFATHERED ASO GROUPS The Affordable Care Act (ACA) requires that certain preventive care drugs and drug categories be covered at no cost to health

More information

Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders

Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP 4 9 4 0 I r v i n e B l v d., S u i t e 2 0 2 I

More information

Information for Vermont Prescribers of Prescription Drugs (Long Form)

Information for Vermont Prescribers of Prescription Drugs (Long Form) The information on this form is provided pursuant to Vermont law 33 V.S.A. section 2005a which requires this disclosure by pharmaceutical marketers. Information for Vermont Prescribers of Prescription

More information

There will be no refunds once services are performed.

There will be no refunds once services are performed. WEIGHT LOSS NEW PATIENT PAPERWORK PATIENT: Name: Last First Address: City: State: Zip Phone: ( ) Alt #( ) Email: DOB: Age: Sex: Occupation: EMERGENCY CONTACTS: (You must list at least one person) Name:

More information

May 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary

May 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary Commercial Triple Tier 4th Tier Applicable Traditional s EVOTAZ 2 2 Alternatives Flovent Diskus/HFA, Pulmicort Flexhaler, Qvar, Asmanex HFA eszopiclone, zaleplon, zolpidem, amitriptyline, mirtazapine,

More information

A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation

A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation A Healthesystems Clinical Analysis Insidious Incrementalism of Opioid Use in Workers Compensation Prescription opioid use in the United States has grown significantly over the past 20 years. In 1991, there

More information

Safe Disposal of Medications and Sharps in the Home Setting. American Nurses Association & U.S. Food and Drug Administration

Safe Disposal of Medications and Sharps in the Home Setting. American Nurses Association & U.S. Food and Drug Administration Safe Disposal of Medications and Sharps in the Home Setting American Nurses Association & U.S. Food and Drug Administration Objectives: Identify the potential human and environmental hazards of sharps

More information

GAO MEDICARE PART D. Instances of Questionable Access to Prescription Drugs. Report to Congressional Requesters

GAO MEDICARE PART D. Instances of Questionable Access to Prescription Drugs. Report to Congressional Requesters GAO United States Government Accountability Office Report to Congressional Requesters September 2011 MEDICARE PART D Instances of Questionable Access to Prescription Drugs GAO-11-699 September 2011 MEDICARE

More information

Drug Utilization Is On The Rise

Drug Utilization Is On The Rise Objectives Identify the clinical issues related to opioid prescribing for chronic pain indications Define the clinical needs and expectations of urine drug testing in pain management Address preanalytical

More information

Pharmacy Benefit Program (Central Region Products)

Pharmacy Benefit Program (Central Region Products) In this section Page General Information About Pharmaceuticals 6.1 Pharmaceutical services 6.1 Premier pharmacy networks 6.1 Pharmaceuticals: The Formulary 6.1 Drug formulary for physicians 6.1 The use

More information

Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)

Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP) Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently

More information

Avoid paying too much for your prescriptions 2015 Aetna Rx Step Program Medicine List

Avoid paying too much for your prescriptions 2015 Aetna Rx Step Program Medicine List Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Avoid paying too much for your prescriptions 2015 Aetna Rx Step Program Medicine List 05.03.392.1 C (10/14) It

More information

Oral Fluid Drug Testing March 23 rd, 2015

Oral Fluid Drug Testing March 23 rd, 2015 Oral Fluid Drug Testing March 23 rd, 2015 Drug Testing Options Breath Blood Meconium Vitreous Hair Sweat Urine Oral Drug Testing Options Oral Fluid and Blood and Breath Actual levels (immediate use, up

More information

Roadmap. Florida Trends in Prescription Drug Abuse. Oath of a Pharmacist. Plantation Chemist Busted

Roadmap. Florida Trends in Prescription Drug Abuse. Oath of a Pharmacist. Plantation Chemist Busted Florida Trends in Prescription Drug Abuse Jennifer A. Fass, PharmD, CPh Clinical Assistant Professor fass@nova.edu Roadmap Discuss Florida Medical Examiners Report Illustrate prescription drug abuse cases

More information

An Overview of Risk Evaluation and Mitigation Strategy (REMS): Elements Related to Medication Use and Dispensing

An Overview of Risk Evaluation and Mitigation Strategy (REMS): Elements Related to Medication Use and Dispensing INDIANA PHARMACISTS ALLIANCE (IPA) CONTINUING PHARMACY EDUCATION (CPE) 2012 Article #9 An Overview of Risk Evaluation and Mitigation Strategy (REMS): Elements Related to Medication Use and Dispensing Authors:

More information

Avoid paying too much for your prescriptions

Avoid paying too much for your prescriptions Quality health plans & benefits Healthier living Financial well-being Intelligent solutions 2016 Aetna Rx Step Program Medicine List Avoid paying too much for your prescriptions It s important to try to

More information

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses

More information

The Challenges of Narcotic Tapering in Chronic Pain Treatment

The Challenges of Narcotic Tapering in Chronic Pain Treatment The Challenges of Narcotic Tapering in Chronic Pain Treatment Speakers: Medical Director, Rosomoff Comprehensive Pain Center, Miami Jewish Health Systems Stuart Sweetser SVP, Clinical Pain Programs, Paradigm

More information

Authorised Products Containing Substances Listed in Schedule 2 of. the Misuse of Drugs Regulations 1988, as amended

Authorised Products Containing Substances Listed in Schedule 2 of. the Misuse of Drugs Regulations 1988, as amended Authorised Products Containing Substances Listed in Schedule 2 of Human medicines the Misuse of Drugs Regulations 1988, as amended Product Name Marketing Authorisation Number Controlled Substance Rapifen

More information

UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE DEPARTMENT OF FAMILY MEDICINE PAIN MANAGEMENT GUIDELINES

UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE DEPARTMENT OF FAMILY MEDICINE PAIN MANAGEMENT GUIDELINES UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE DEPARTMENT OF FAMILY MEDICINE PAIN MANAGEMENT GUIDELINES I. OVERVIEW Detailed narcotic prescribing guidelines are outlined in this chapter, but the basic

More information

PRESCRIPTION DRUG ABUSE

PRESCRIPTION DRUG ABUSE PRESCRIPTION DRUG ABUSE Carl M. Dawson, M.S., MAC, LPC - National Drug Court Institute ( NDCI ) Washington, D. C. - The School of Professional Psychology at Forest Institute Springfield, Missouri ( cdawson1028@yahoo.com

More information

Urine Drug Toxicology and Pain Management Testing. Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA

Urine Drug Toxicology and Pain Management Testing. Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA Urine Drug Toxicology and Pain Management Testing Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA Learning Objectives Describe what chronic pain is, who is affected and

More information

Please be sure to list all therapies that have been previously tried on the request form so that your request can be processed in a timely manner.

Please be sure to list all therapies that have been previously tried on the request form so that your request can be processed in a timely manner. Drug Therapy Guidelines: Migraine Agents Axert (almotriptan), Relpax (eletriptan), Frova (frovatriptan), Amerge (naratriptan), Maxalt/MLT (rizatriptan), Imitrex (sumatriptan), Zomig/ZMT (zolmitriptan),

More information

Visit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options

Visit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.

More information

Thinking Outside the Box for the Treatment of Cancer Pain

Thinking Outside the Box for the Treatment of Cancer Pain Thinking Outside the Box for the Treatment of Cancer Pain Suzette Walker, MSN, FNP-C, AOCNP DNPc Co-Director Symptom Management & Supportive Care Program University of Michigan Comprehensive Cancer Center

More information

How To Understand The Health Effects Of Prescription Drugs

How To Understand The Health Effects Of Prescription Drugs Miami-Dade, Broward and Palm Beach Counties, Florida Trends of Nonmedical Prescription Drug Misuse in Miami-Dade, Broward, Palm Beach Counties, and the State of Florida: 2010 James N. Hall 1 ABSTRACT The

More information

Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers

Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer

More information

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015**

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** Disclaimer This presentation was created to assist in the education of EMTs in Naloxone administration.

More information

Overall Drug Trends in. Artemis Emslie VP of Pharmacy Product Development

Overall Drug Trends in. Artemis Emslie VP of Pharmacy Product Development Overall Drug Trends in Workers Compensation Artemis Emslie VP of Pharmacy Product Development Workers compensation PBM industry overview PBM's addressable market approximates $5 billion and is growing

More information

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential

More information

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only Updated 5.5.14 NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only 68152-0103-03 A9543 YTTRIUM Y-90 IBRITUMOMAB TIUXETAN ZEVALIN Y-90 VIAL 9/1/2013 12/31/2013 50419-0320-05

More information

PtProtect Pain Medication Management Program Monitors Patient Compliance

PtProtect Pain Medication Management Program Monitors Patient Compliance PHYSICIAN UPDATE 2013 Edition PtProtect Pain Medication Management Program Monitors Patient Compliance The PtProtect (Patient Protect) program offers pain medication management panels designed to improve

More information

SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2010) Substance Use Disorders E. 2

SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2010) Substance Use Disorders E. 2 SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2010) Substance Use Disorders E. 2 *LIFETIME ALCOHOL ABUSE* IF DEFINITE PERIOD: Let me ask you a few more questions about (TIME WHEN DRINKING THE MOST OR HAD PROBLEMS).

More information

Behavioral Health Indicators for Tennessee and the United States

Behavioral Health Indicators for Tennessee and the United States Behavioral Health Indicators for Tennessee and the United States April 2015 Prepared by: Lymari Benitez, Ph.D. and Rachel L. Jones Tennessee Department of Mental Health and Substance Abuse Services Office

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

WV Prescription Drug Abuse Quitline

WV Prescription Drug Abuse Quitline WV Prescription Drug Abuse Quitline WVPDAQ January 2010 Volume 1, Issue 1 Welcome to the West Virginia Prescription Drug Abuse Quitline Newsletter. Our goal is to work together to address the growing problem

More information

FLORIDA DEPARTMENT OF LAW ENFORCEMENT SEPTEMBER 2013. 2012 Report

FLORIDA DEPARTMENT OF LAW ENFORCEMENT SEPTEMBER 2013. 2012 Report FLORIDA DEPARTMENT OF LAW ENFORCEMENT SEPTEMBER 2013 2012 Report Data Collection The Office of Vital Statistics reported more than 178,000 deaths occurred in Florida during 2012. Of these, the medical

More information

Medications and Recovery An Important Piece of the Puzzle

Medications and Recovery An Important Piece of the Puzzle Medications and Recovery An Important Piece of the Puzzle Second Edition A guide to maintaining sobriety while receiving treatment for other health problems Renee Enstrom, Pharm.D., R.Ph. Richard Zinni,

More information

Updated MAR 26, 2013 Myelography Seizures:

Updated MAR 26, 2013 Myelography Seizures: Updated MAR 26, 2013 Myelography Medications to be evaluated prior to myelography. This list is to assist the radiologist, pharmacist, and radiology technologist in evaluating medication risk associated

More information

WELCOME TO OUR PRACTICE

WELCOME TO OUR PRACTICE WELCOME TO OUR PRACTICE Please answer the following questions so we can better assist your healthcare needs. PATIENT INFORMATION Date Soc. Sec. # Birth Date Name (Last Name) (First Name) (Initial) (Maiden

More information

Medication Assisted Treatments for Opioid Dependence & Barriers to Implementation

Medication Assisted Treatments for Opioid Dependence & Barriers to Implementation Medication Assisted Treatments for Opioid Dependence & Barriers to Implementation 9th Annual Midwest Conference on Problem Gambling and Substance Abuse Erin L. Winstanley, Ph.D. University of Cincinnati

More information

New Mexico Drug Donation Guide

New Mexico Drug Donation Guide New Mexico Drug Donation Guide 16.19.34.2 SCOPE: This section applies to licensed clinics and participating practitioners located within the state of New Mexico who provide for the donation and redistribution

More information

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),

More information

N a s d a q : I N S Y

N a s d a q : I N S Y N a s d a q : I N S Y Michael L. Babich, President and Chief Executive Officer Darryl S. Baker, Chief Financial Officer Jeffries Healthcare Conference, June 2014 Safe Harbor Statement This presentation

More information

Prescription Opioid Analgesic Dependence and Addiction: Experience in the United States

Prescription Opioid Analgesic Dependence and Addiction: Experience in the United States Prescription Opioid Analgesic Dependence and Addiction: Experience in the United States October 10, 2013 Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center Professor, University of

More information

Pain Management: Acute and Chronic. Rita Volochayev, FNP-C

Pain Management: Acute and Chronic. Rita Volochayev, FNP-C Pain Management: Acute and Chronic Rita Volochayev, FNP-C Course Objectives Upon completion of this presentation participants should be able to: Discuss the definition of pain, its prevalence describe

More information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency

More information

UMP Classic 2015 High Cost Generic Tier 2 Drug Program

UMP Classic 2015 High Cost Generic Tier 2 Drug Program UMP Classic 2015 High Cost Generic Tier 2 Program The listing below identifies select generic medications that are covered under Tier 2 coinsurance level and possible cost effective alternatives. For additional

More information

2016 Comprehensive List of Covered Drugs

2016 Comprehensive List of Covered Drugs Healthcare Marketplace Comprehensive Exchange Drug List: CY2016 2016 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Covered persons

More information

Protecting Your Practice and Patients Tackling Prescription Drug Abuse Accreditation Pharmacists: 0798-0000-12-040-L05-P Nurses: N-764

Protecting Your Practice and Patients Tackling Prescription Drug Abuse Accreditation Pharmacists: 0798-0000-12-040-L05-P Nurses: N-764 Page 1 Protecting Your Practice and Patients Tackling Prescription Drug Abuse Accreditation Pharmacists: 0798-0000-12-040-L05-P Nurses: N-764 CE Credit(s) 1.0 contact hour(s) Protecting Your Practice and

More information

Abilify (aripiprazole) Abilify oral solution

Abilify (aripiprazole) Abilify oral solution Responsible Quantity Program* (Programa Responsible Quantity*) Current (Corriente) 10/1/15 Quantity Limit Authorization Form (Formulario de límite de Responsible Quantity) Responsible Quantity program

More information

Blueprint for Prescriber Continuing Education Program

Blueprint for Prescriber Continuing Education Program CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting

More information

What Parents Need to Know

What Parents Need to Know What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to

More information

DRUG AND ALCOHOL PREVENTION POLICY

DRUG AND ALCOHOL PREVENTION POLICY DRUG AND ALCOHOL PREVENTION POLICY Georgia Christian University complies with all federal, state, and local laws and policies on the abuse of alcohol and other drugs by its students. GCU Policy on Drug

More information

Tier 1 Formulary Drug Quantity Limits 2016

Tier 1 Formulary Drug Quantity Limits 2016 Tier 1 Formulary Drug Quantity Limits 2016 Updated: 11/20/2015 Effective: 01/01/2016 What are Quantity Limits? For certain drugs, we limit the amount of the drug that you can have by limiting how much

More information

Summary of Children s Safety Network Prescription and Over-the-Counter Drug Abuse Environmental Scan

Summary of Children s Safety Network Prescription and Over-the-Counter Drug Abuse Environmental Scan Summary of Children s Safety Network Prescription and Over-the-Counter Drug Abuse Environmental Scan Introduction Prescription and over-the-counter (OTC) drug abuse and its consequences are a fast growing

More information

How To Get A Generic Drug From A Pharmacy Benefit Manager

How To Get A Generic Drug From A Pharmacy Benefit Manager Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative

More information

FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House

FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House Background While the use of illegal drugs like cocaine and heroin is falling, more people

More information

8/23/2015 A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH

8/23/2015 A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH 8/23/2015 A Practical Optometric Approach To Headaches Leonid Skorin, Jr., OD, DO, MS, FAAO, FAOCO Consultant, Department of Surgery Community Division of Ophthalmology Mayo Clinic Health System in Albert

More information

www.oxfordhealth.com

www.oxfordhealth.com www.oxfordhealth.com Oxford s HMO products are underwritten by Oxford Health Plans (NY), Inc., Oxford Health Plans (NJ), Inc., and Oxford Health Plans (CT), Inc., and insurance products are underwritten

More information

Pharmacy Manual. The information contained in this Pharmacy Manual does not apply to pharmacy providers from the province of Quebec.

Pharmacy Manual. The information contained in this Pharmacy Manual does not apply to pharmacy providers from the province of Quebec. Pharmacy Manual The information contained in this Pharmacy Manual does not apply to pharmacy providers from the province of Quebec. Table of Contents Section 1 - General Information About TELUS Health

More information

Magellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs)

Magellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs) Magellan Rx Medicare Basic (PDP) 2016 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE S WE COVER IN THIS PLAN Formulary File 16144, Version 22 This formulary

More information

CROSSROADS AFTERCARE PROGRAM, INC.

CROSSROADS AFTERCARE PROGRAM, INC. CROSSROADS AFTERCARE PROGRAM, INC. MISSION Crossroads Aftercare Program is a residence for addiction recovery designed to support men and women who have historically struggled with chemical dependency

More information

Reducing Narcotics Misuse and Abuse in Workers Compensation

Reducing Narcotics Misuse and Abuse in Workers Compensation Reducing Narcotics Misuse and Abuse in Workers Compensation Trusted. Reliable. Sustainable. Page 2 Introduction Narcotics have a long history of being used to therapeutically treat pain resulting from

More information

Good Practice Guidance: The safe management of controlled drugs in care homes

Good Practice Guidance: The safe management of controlled drugs in care homes Good Practice Guidance: The safe management of controlled drugs in care homes Medicines Management Social Care Support Team Reviewed April 2015 Good Practice Guidance: The safe management of controlled

More information

Drug Diversion Training and Best Practice Prescribing for West Virginia Nurses (1 CH)

Drug Diversion Training and Best Practice Prescribing for West Virginia Nurses (1 CH) Drug Diversion Training and Best Practice Prescribing for West Virginia Nurses (1 CH) COPYRIGHT 2014, WILD IRIS MEDICAL EDUCATION, INC. ALL RIGHTS RESERVED. Contact Hours: 1 This is a complimentary PDF

More information

Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers

Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers Treatment Options for ADHD in Children and Teens A Review of Research for Parents and Caregivers Is This Summary Right for Me? Yes, if: A doctor said that your child or teen has attention deficit hyperactivity

More information

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina

More information

OPIOIDS CONVERSION GUIDELINES 2007

OPIOIDS CONVERSION GUIDELINES 2007 Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating

More information

Patient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg

Patient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg Patient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg Read this Patient Information before you start using ONZETRA Xsail and each time you get a refill. There

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

Understanding Your Pain

Understanding Your Pain Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.

More information

2015 Formulary (List of Covered Drugs)

2015 Formulary (List of Covered Drugs) Blue Cross Medicare Advantage Basic (HMO) SM Blue Cross Medicare Advantage Premier Plus (HMO-POS) SM 015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS

More information

Care Guide: Cancer Pain

Care Guide: Cancer Pain Care Guide: Cancer Pain Key Points: Cancer Pain Specific Pain Problems 1. Pain is defined as an independent and emotional experience associated with actual or potential tissue damage or described in terms

More information

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid? Opioid Addiction & Methadone Maintenance Treatment Dr. Nick Wong MD, CCFP AADAC Edmonton ODP AADAC AHMB Concurrent Disorder Series September 13, 2007 1 What is Methadone? What is methadone? Synthetic opioid.

More information

Practitioner s Manual

Practitioner s Manual United States Department of Justice Drug Enforcement Administration Office of Diversion Control An Informational Outline of the Controlled Substances Act Joseph T. Rannazzisi Deputy Assistant Administrator

More information

Annual Notice of Changes for 2016

Annual Notice of Changes for 2016 Blue Cross Community MMAI offered by Blue Cross and Blue Shield of Illinois Annual Notice of Changes for 2016 You are currently enrolled as a member of the Blue Cross Community MMAI Plan. Next year, there

More information

Naloxone treatment of opioid overdose

Naloxone treatment of opioid overdose Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing

More information

Medication-Assisted Treatment for Opioid Addiction

Medication-Assisted Treatment for Opioid Addiction Medication-Assisted Treatment for Opioid Addiction Facts for Families and Friends U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance

More information

22 nd National Conference Pharmaceutical and Chemical Diversion. Pharmaceutical Drug Abuse & Trafficking Trends September 30, 2014

22 nd National Conference Pharmaceutical and Chemical Diversion. Pharmaceutical Drug Abuse & Trafficking Trends September 30, 2014 22 nd National Conference Pharmaceutical and Chemical Diversion Pharmaceutical Drug Abuse & Trafficking Trends September 30, 2014 Ruth A. Carter, Chief Liaison and Policy Section Ruth.A.Carter@usdoj.gov

More information

Toxicology CPT Code Changes for 2016

Toxicology CPT Code Changes for 2016 Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G

More information

West Virginia Department of Health and Human Resources Bureau for Public Health Office of Emergency Medical Services

West Virginia Department of Health and Human Resources Bureau for Public Health Office of Emergency Medical Services OEMSI==o..-::::::- 9 ---- ~ West Virginia Controlled Substance Policy Statement This policy establishes the standard for the management of Controlled Substances by WV EMS agencies in accordance with Federal

More information

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists, BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module II Opioids 101 Goals for Module II This module reviews the following: Opioid addiction and the brain Descriptions

More information

Trends of Opioid Misuse and Diversion: Lessons from the United States

Trends of Opioid Misuse and Diversion: Lessons from the United States Trends of Opioid Misuse and Diversion: Lessons from the United States 31 October 2012 Richard C. Dart, MD, PhD Director Rocky Mountain Poison and Drug Center Professor - University of Colorado, Department

More information